Literature DB >> 25456748

Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome.

I Oschlies1, I Simonitsch-Klupp, J Maldyk, D Konovalov, D Abramov, N Myakova, J Lisfeld, A Attarbaschi, U Kontny, W Woessmann, W Klapper.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25456748     DOI: 10.1111/bjd.13440

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Recent advances in cutaneous lymphoma-implications for current and future classifications.

Authors:  J R Goodlad; L Cerroni; S H Swerdlow
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

Review 2.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2015-03-07       Impact factor: 0.196

3.  Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone.

Authors:  Dinesh P Asati; Vaibhav Ingle; Deepti Joshi; Anurag Tiwari
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

4.  A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling.

Authors:  Yang Zhang; Zhihua Wang; Guoyu Hu; Jieping Li; Yongheng Chen; Yi Jiang; Haiying Zhong; Xianling Liu; Chunhong Hu; Honglin Peng; Yunxiao Xu; Zhao Cheng; Guangsen Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

5.  Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography evaluation of subcutaneous panniculitis-like T cell lymphoma and treatment response.

Authors:  Vadim R Gorodetskiy; Olga V Mukhortova; Irakli P Aslanidis; Wolfram Klapper; Natalya A Probatova
Journal:  World J Clin Cases       Date:  2016-09-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.